110 related articles for article (PubMed ID: 7038749)
1. Effects of piperazinedione (NSC 135785) plus irradiation on endogenous CFU-S, intestinal crypts, and as a possible ablative protocol for marrow transplantation as evaluated in Rauscher leukemic mice.
Meredith RF; Okunewick JP; Kovacs CJ; Evans MJ; Dicke KA
Radiat Res; 1982 Mar; 89(3):559-74. PubMed ID: 7038749
[No Abstract] [Full Text] [Related]
2. Piperazinedione (NSC 135758) and total body irradiation as an ablative bone marrow transplantation regimen in mice.
Zander AR; Huynh L; Spitzer G; Verma DS; Dicke KA
Exp Hematol; 1981 Oct; 9(9):945-9. PubMed ID: 7040096
[TBL] [Abstract][Full Text] [Related]
3. Radiation sensitizing and radiation protective agents in experimental radiation therapy.
Ambrus JL; Halpern J; Bardos T; Chmielwicz ZF; Klein E
J Med; 1988; 19(5-6):369-81. PubMed ID: 3060557
[TBL] [Abstract][Full Text] [Related]
4. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
[TBL] [Abstract][Full Text] [Related]
5. Total lymphoid irradiation (TLI) and allogeneic marrow transplantation for enzyme replacement therapy and immunotherapy of leukemia in mice.
Slavin S; Yatziv S; Weiss L; Morecki S; Abeliuk P; Fuks Z
Transplant Proc; 1981 Mar; 13(1 Pt 1):439-42. PubMed ID: 7022868
[No Abstract] [Full Text] [Related]
6. Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD.
Cooper MH; Patrene KD; Vecchini F; Austin CA; Markus PM; Boggs SS
Bone Marrow Transplant; 1994 Sep; 14(3):355-62. PubMed ID: 7527689
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study of the antileukemic effect of Endoxan in combination with bone marrow cell and spleen cell transplantation].
Bergol'ts VM; Sukhin GM
Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):36-9. PubMed ID: 4900638
[No Abstract] [Full Text] [Related]
8. CFU-S repopulation after low-dose whole-body radiation.
Schofield R; Dexter TM
Radiat Res; 1982 Mar; 89(3):607-17. PubMed ID: 7038750
[No Abstract] [Full Text] [Related]
9. [Study of experimental mixed bone marrow transplantation].
Luo H; Yang P; He F
Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):418-21. PubMed ID: 11189509
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation.
Terenzi A; Aristei C; Aversa F; Pasqualucci L; Albi N; Velardi A; Latini P; Martelli MF
Transplant Proc; 1994 Dec; 26(6):3217. PubMed ID: 7998120
[No Abstract] [Full Text] [Related]
11. Efficacy of piperazinedione prior to bone marrow transplantation: studies in a rat model for human acute myelocytic leukemia.
Hagenbeek A; Martens AC
Cancer Treat Rep; 1981; 65(7-8):575-82. PubMed ID: 7018679
[TBL] [Abstract][Full Text] [Related]
12. The critical influence of timing of combined modality cytoreductive regimens.
Peters LJ; Mason KA; Marles A
Exp Hematol; 1979; 7 Suppl 5():290-6. PubMed ID: 400691
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of neocarzinostatin, effect on Rauscher leukemia in mice.
Takahashi I; Sakato J; Mikochi H; Moriwaki H; Kitajima K; Irino S; Hiraki K
Acta Med Okayama; 1974 Aug; 28(4):271-6. PubMed ID: 4280236
[No Abstract] [Full Text] [Related]
14. Survival of spleen colony-forming units (CFU-S) of irradiated bone marrow cells in mice: evidence for the existence of a radioresistant subfraction.
Inoue T; Hirabayashi Y; Mitsui H; Sasaki H; Cronkite EP; Bullis JE; Bond VP; Yoshida K
Exp Hematol; 1995 Nov; 23(12):1296-300. PubMed ID: 7589285
[TBL] [Abstract][Full Text] [Related]
15. Colony forming unit suicide in normal and Rauscher leukemic mice given tritiated thymidine in vivo.
Okunewick JP; Phillips EL
Exp Hematol; 1974; 2(1):9-15. PubMed ID: 4455510
[No Abstract] [Full Text] [Related]
16. [Study of the effect of reumycin on hemopoiesis normal animals and in some forms of experimental leukosis].
Khanykova OK; Koropov IV
Antibiotiki; 1968 Jun; 13(6):501-5. PubMed ID: 5678105
[No Abstract] [Full Text] [Related]
17. [Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice].
Xu KL; Ju JP; Pan XY; Du B; Li ZY; Lu QX
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):372-5. PubMed ID: 12941194
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of CD3 and CD5 donor T cell depletion on graft-versus-leukemia in a murine model for MHC-matched unrelated-donor transplantation.
Okunewick JP; Kociban DL; Machen LL; Buffo MJ
Bone Marrow Transplant; 1994 Jan; 13(1):11-7. PubMed ID: 7517254
[TBL] [Abstract][Full Text] [Related]
19. Effect of split dose TBI on hematopoietic stem-cell survival in combined radiation-drug exposures.
OKunewick JP; Buffo MJ; Kociban DL
Int J Radiat Oncol Biol Phys; 1984 Jul; 10(7):1087-93. PubMed ID: 6378846
[TBL] [Abstract][Full Text] [Related]
20. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
